Lupin Ltd KYS Report: Ownership & Insights

15:59 Dec 12

Lupin Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2113.90

+32.10 (+1.54%)

NSE BSE

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lupin Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 15:59 Dec 12

2113.90

+32.10 (+1.54%)

70/100 High Financial Strength

Quality

44/100 Mid Valuation

Valuation

54/100 Technically Neutral

Technical

SWOT

Strength

Weakness

Opportunity

Threat

96.56K

Market Cap (Cr)

22.33

PE Ratio

4.92

Price to Book Ratio

65.41

RSI

14.45 %

Net Profit Margin

Rating Based on 10 Analysts

Buy 80%

Hold 20%

Sell 0%

Buy

The consensus recommendation from 8 analysts for Lupin Ltd. is Buy

Analyst Price Target

The average price target is 2328 with a high estimate of 2626 and low estimate of 1950

High Average Low

Current 2113.90

2626.00

2328.00

1950.00

Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation

SWOT

Strength Weakness Opportunity Threats

Download Our App On:

Back

Back

Back

Back

OTP sent to your mobile number. Please enter it below to verify.

59 s

Verify Email OTP

OTP sent to

Didn’t receive a code? Don’t worry Retry in 59 s

Dear User,
please complete your profile!

Email ID Already Exists

Location Saved Successfully

Email Id Verified Successfully

Complete 2 steps process within few minutes

Step 2

OR

Enter OTP Sent on Your

59 s

Back

59 s

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password